Switch to:
GuruFocus articles
Headlines from internet
Nov-17-17$83.98 (+1.16%)
07:44AMCelgene CAR-T Therapy Gets Breakthrough Therapy Designation Zacks
Nov-16-17$83.02 (+0.51%)
09:59AMWhy is Alnylam's (ALNY) Stock Up More Than 200% this Year? Zacks
08:00AMWatch Gilead Junos Strategy Might Just Pay Seekingalpha
06:55AMIncyte (INCY) Initiates Essential Thrombocythemia Trial Zacks
Nov-15-17$82.6 (-0.52%)
10:20AMRoche (RHHBY) Receives FDA Clearance for Ventana MMR Test Zacks
Nov-14-17$83.03 (+0.39%)
02:02PMHealthcare Dogfight Glaxosmithkline Regains Top Gains November O And M And Patterson Close Seekingalpha
01:17PMNovartis Nvs R And D Investor Presentation Slideshow Seekingalpha
12:48PMStock Market Cycle Implications Medical Stock Investing Seekingalpha
07:34AM3 Top Big Pharma Dividend Stocks You Can Buy Right Now Fool
07:31AMNovartis (NVS) Arm's Biosimilars Study Results Encourage Zacks
Nov-13-17$82.71 (+0.4%)
09:00AMCan Marijuana Cure Alzheimer's Disease? Fool
08:04AMNovartis Looks Challenge Regenerons Turf Will Win War Seekingalpha
Nov-12-17
10:43AMValeant Surges Post Q3 Reassessment Seekingalpha
09:09AMBetter Buy: Exelixis, Inc. vs. Novartis AG Fool
Nov-11-17
08:00AM3 Things Biotech Learn Today November 11 2017 Seekingalpha
Nov-10-17$82.38 (-0.12%)
03:30PMMomenta Pharmaceuticals, Inc.'s Rough Month Fool
09:52AMLigand (LGND) Q3 Earnings & Revenues Top, 2017 View Raised Zacks
08:30AMImpax (IPXL) Q3 Earnings & Revenues Beat Estimates, Fall Y/Y Zacks
Nov-09-17$82.48 (-0.55%)
08:16AMOphthotech (OPHT) Q3 Earnings & Sales Beat, Zimura in Focus Zacks
Nov-07-17$82.39 (-1.33%)
03:37PMIs This Why Glaukos Corp. Is Tumbling Today? Fool
01:08PMHere's Why Advanced Accelerator Application SA Rose 20% in October Fool
12:01PMDaily Pharma Scoop Anxious Time Dynavax Longs Vbl Therapeutics Gets Boost Roche Gets 2 Fda Seekingalpha
Nov-06-17$83.5 (-0.24%)
02:32PMWhat's in Store for Ligand (LGND) This Earnings Season? Zacks
02:27PMWill Mylan Crush Teva’s Generic Dreams? Barron's
12:02PMComments Q3 Results Merck Pfizer Bristol Myers Novo Nordisk Seekingalpha
10:00AM3 Stocks Changing the Future of Healthcare Fool
07:32AMPharma Stock Roundup: Pfizer, Teva's Q3 Earnings, Novartis Seeks New Indication for Kymriah Zacks
Nov-03-17$83.7 (+1.11%)
11:02AMTeva (TEVA) Stock Plunges 20% on Q3 Earnings Miss & View Cut Zacks
09:23AM3 Reasons Behind Exelixis Stock's Big Bounce Fool
08:34AM3 Reasons It's Smart to Buy Celgene's Stock Now Fool
Nov-02-17$82.78 (+0.01%)
05:03PMNovartis Reportedly Taps Centerview to Evaluate Options for Dermatology Business theStreet
02:49PMWhy Juno Therapeutics Shares Are Going Up 21.2% Today Fool
09:19AMConatus (CNAT) Loss Wider Than Expected in Q3, Sales Miss Zacks
09:03AMJuno Therapeutics' 3rd Quarter Boosted by Potential Rival Novartis Fool
09:02AMIntercept (ICPT) Q3 Loss Narrower Than Expected, Sales Beat Zacks
09:01AM5 Things Pfizer's Management Just Said That You Don't Want to Miss Fool
08:18AMGlaxoSmithKline Wins FDA Approval to Develop 'Breakthrough' Blood Cancer Drug theStreet
08:00AM3 Things Biotech Learn Today November 2 2017 Seekingalpha
07:54AM5 Biotech and Pharma Stocks with Key FDA Catalysts this November Zacks
07:01AMWall Street Breakfast Prepare Powell Fed Seekingalpha
Nov-01-17$82.77 (+0.23%)
04:07PMBiotechs Behaving Badly Analysis Seekingalpha
02:05PMIncyte Tops Q3 Earnings & Sales, Extends AstraZeneca Deal Zacks
11:11AMNow that Novartis is buying AAA, I’m zeroing in on this potential pharma target MarketWatch
11:05AMAduro (ADRO) Q3 Loss In Line With Estimates, Revenues Miss Zacks
09:46AMCan Juno Therapeutics Outmaneuver Its CAR-T Competitors? Fool
08:29AMMomenta shares plunge 14% on Q3 profit, revenue misses MarketWatch
08:00AM3 Things November 1 2017 Geron Fast Track Astrazenecas New Approval Novartis Tackles Dlbcl Seekingalpha
06:45AMGlaxosmithkline Comparative Analysis Potential Takeover Targets Cash Flow Dividend Seekingalpha
Oct-31-17$82.58 (+1.03%)
03:51PMNovartis Buys French Radiopharmaceutical Company Zacks
02:14PMMylan: Can 18 Companies Collude? Barron's
01:19PMTeva earnings: Facing down cheaper generic prices, generic competition of its own and a lot of debt MarketWatch
07:59AMAdvanced Accelerator (AAAP) in Focus: Stock Moves 10.4% Higher Zacks
03:00AMBiotech Analysis Central Daily Pharma News October 30 2017 Seekingalpha
Oct-30-17$81.74 (+1.26%)
04:53PMWhat's in Store for Juno Therapeutics (JUNO) in Q3 Earnings? Zacks
04:09PMWashington Uncertainty and a Healthcare Selloff Send Stocks Off Kilter theStreet
12:36PMWhy Advanced Accelerator Applications SA Acquired a Higher Price Today Fool
12:10PMInterested Rare Disease Segment Put Ionis Pharmaceuticals Shopping List 2017 Seekingalpha
11:48AMGM Takes Down Consumer Stocks, Tech Rally Fails to Hold Up theStreet
11:20AMEuropean Merger Space Sees Q4 Sweet Spot of Cheap Stocks, Easy Financing theStreet
09:36AMStocks Fall as Mueller Probe Triggers Uncertainty in Washington, Wall Street theStreet
09:01AMForeign Stock Roundup: Novartis, Bayer, Glaxo, Total Beat on Earnings Zacks
08:06AMStarbucks Might Be About to Shock the Hell Out of Wall Street theStreet
07:57AMStock Futures Under Pressure as Wall Street Awaits a Break in Mueller Probe theStreet
07:00AMWall Street Breakfast Bitcoin Sets New Time High Seekingalpha
06:40AMRail Stocks Good Cramers Lightning Round 10 27 17 Seekingalpha
06:06AMNovartis, Akzo Nobel and Axalta - 5 Things You Must Know Before the Market Opens Monday theStreet
04:03AMNovartis To Buy Advanced Accelerator for $3.9 Billion in Oncology Push theStreet
Oct-29-17
11:41AM3 Biotech Stocks That Turned $1,000 Into More Than $5,000 This Year Fool
08:15AMA Me-Too Push By Biopharma Is Crowding the Psoriasis Market Fool
Oct-27-17$80.72 (-0.23%)
08:22PMBaozun, J.M. Smucker Co., Southwest, Novartis: 'Mad Money' Lightning Round theStreet
01:54PMGilead Bad News Good News Guesses Seekingalpha
12:11PMWhat's in Store for Conatus (CNAT) This Earnings Season? Zacks
07:19AMThe Zacks Analyst Blog Highlights: Visa, Coca-Cola, United Technologies, AT&T and Novartis Zacks
06:08AM3 Key Things to Watch in Pfizer's Q3 Results Fool
Oct-26-17$80.91 (-0.57%)
02:36PMTop Analyst Reports for Visa, Coca-Cola & United Technologies Zacks
01:09PMGilead Sciences Dividend Growth Potential Reasonable Value Seekingalpha
12:04PMDaily Pharma Scoop Roches Investment Potential Sarepta Lifts Guidance Pfizer Restructuring Seekingalpha
11:28AMMedicines Company (MDCO) Reports Q3 Loss, Revenues Miss Zacks
10:21AMAmgen (AMGN) Q3 Earnings Top, Sales Decline Y/Y, Stock Falls Zacks
07:37AM5 Intriguing Things Illumina's Management Said in Its Q3 Update Fool
Oct-25-17$81.37 (-2.12%)
08:49AMDrug Stock Q3 Earnings Roster for Oct 26: GILD, BMY & More Zacks
Oct-24-17$83.13 (-3.24%)
04:01PMPositive Earnings Drive Dow to New Record in Best Performance in a Month theStreet
03:55PMNovartis Q3 2017 Strong Signals Wait Better Entry Point Seekingalpha
01:52PMNovartis Ag 2017 Q3 Results Earnings Call Slides Seekingalpha
11:08AMDow Sees Best Gain of October After Caterpillar, 3M Earnings Beat theStreet
09:38AMStrong Quarters From Caterpillar, 3M and McDonald's Drive Dow to Solid Gains theStreet
09:03AMNovartis (NVS) Q3 Earnings & Sales Top on New Drugs Strength Zacks
08:54AMNovartis may still spin off Alcon, but not before 2019 MarketWatch
08:17AMIs Regeneron Pharmaceuticals, Inc. Stock a Buy? Fool
08:12AMDrug/Biotech Stocks Q3 Earnings on Oct 25: AMGN, GSK, VRTX Zacks
08:00AM3 Things October 24 2017 Novartis Breaks Pfizer Looks Io Chemo Antaress Bad News Seekingalpha
07:46AMBurst of Earnings Keeps Premarket Trade Busy, Stock Futures Rise theStreet
07:04AMWall Street Breakfast Frenzy Builds Taxes Fed Chair Seekingalpha
06:05AMMcDonald's, Sears and Amazon - 5 Things You Must Know Before the Market Opens Tuesday theStreet
04:25AMAmazon, Novartis and Netflix - This is What You Need to Know on Tuesday theStreet
02:53AMNovartis Tops Estimates Boosted by New Drugs theStreet
Oct-23-17$85.91 (+0.2%)
03:05PMMight Best Time Pick Aerie Pharmaceuticals 2017 Seekingalpha
10:04AMBig Biotech Crispr Game Novartis Vertex Lead Pack Seekingalpha
08:23AMGilead Drug Approval Fuels Interest in CAR-T Space: 3 Stocks to Consider Zacks
07:10AMKey Predictions for Q3 Earnings Reports of LLY, BIIB, NVS Zacks
Oct-20-17$85.74 (-0.49%)
04:51PMRoche (RHHBY) Reports Sales Numbers for First 9 Months Zacks
04:45PMGilead (GILD) CAR-T Therapy Yescarta Clinches FDA Approval Zacks
04:28PMCancer Treatment Update: Second Gene Therapy Receives Approval Zacks
09:55AMGlaxo (GSK) Q3 Earnings: Will it Deliver a Beat Yet Again? Zacks
09:50AMWhat's in the Cards for Amgen (AMGN) this Earnings Season? Zacks
09:22AMConatus' Liver Disease Drug Gets Orphan Drug Tag in the EU Zacks
Oct-19-17$86.16 (+0.14%)
07:31PMGilead Slaps Mega-Price on Its Newly Approved CAR-T Fool
04:10PMBiotech Forum Daily Digest Spotlighting Ignytas Big Recent Rally Seekingalpha
03:09PMYes Car T Therapy May Mean Gilead Seekingalpha
08:51AMCan ImmunoGen's Key Pipeline Cancer Candidate Drive Growth? Zacks
08:36AMConatus Entrusts Keith W. Marshall With Key Management Roles Zacks
08:20AMTeva Submits BLA to FDA for Migraine Candidate Fremanezumab Zacks
08:04AMGilead Stock Climbs as FDA Approves Lymphoma Cancer Therapy Drug Yescarta theStreet
08:00AMNovartis Reports Positive Results on Thrombocytopenia Drug Zacks
02:17AMFda Approval Gilead Car T Therapy Will Move Needle Seekingalpha
Oct-18-17$86.04 (-0.35%)
06:20PMGilead shares rise after FDA approves cell-therapy drug Yescarta MarketWatch
03:21PMWhat to Expect from Big Pharmas After J&J's Solid Q3 Results? Zacks
09:36AMHealthcare Dogfight Owens And Minor Edges Glaxosmithkline Top Broker Pick Gains October Seekingalpha
05:36AMWhat's in the Cards for Novartis (NVS) This Earnings Season? Zacks
Oct-17-17$86.34 (-0.03%)
06:17PMBetter Buy: Ziopharm Oncology, Inc. vs. Celldex Therapeutics Fool
04:59PMAerie (AERI) Up on FDA Review Committee Result for Rhopressa Zacks
02:55PMInnovative Pipelines & Regulatory Catalysts to Drive Pharma Stocks Zacks
Oct-16-17$86.37 (+0.28%)
11:42AMWall Street on Track to Close at Fresh Records as Energy Rises theStreet
11:21AMSanofi Upward Trajectory 2017 Seekingalpha
Oct-15-17
07:03AMThe 1 Stock You've Been Overlooking for Your Roth IRA Fool
Oct-14-17
08:00AM3 Things Biotech Learn Today October 14 2017 Seekingalpha
Oct-13-17$86.13 (+0.16%)
03:44PMSpark Therapeutics’ promising gene therapy for vision loss could cost $1 million MarketWatch
09:23AMBristol-Myers (BMY), TARGET Extend Partnership for NASH Study Zacks
08:02AMLilly's Verzenio Gets Priority Review in First-Line Setting Zacks
07:00AM3 Things Biotech Learn Today October 13 2017 Seekingalpha
Oct-12-17$85.99 (-0.46%)
07:26PMFDA Advisory Committee Greenlights First Gene Therapy For Inherited Disorder theStreet
05:45PMNon-Alcoholic Steatohepatitis 2017 Progress Update Zacks
Oct-11-17$86.39 (+0.76%)
11:46AMBiotech Analysis Central Daily Pharma News Seekingalpha
09:40AMLilly's (LLY) Verzenio Fails in Phase III Lung Cancer Study Zacks
07:20AMMylan Deals a Blow to Teva Pharmaceutical Fool
Oct-10-17$85.74 (+0.34%)
07:00PMAmgen Wins Reprieve on Its 2nd-Best-Selling Drug Fool
10:20AMEli Lilly Loses Some Luster Barron's
06:02AM$50,000 Per Year in Prescription Drugs? You Likely Know Someone Who Used at Least That Much Fool
Oct-09-17$85.45 (-0.37%)
09:00AMPfizer Growth Trajectory Locked Ready Launch Seekingalpha
07:55AMMarijuana Stocks Growing Like Weed Seekingalpha
Oct-08-17
01:05PMUnited Therapeutics Seems Time Sell Stock 2017 Seekingalpha
Oct-06-17$85.77 (+0.15%)
01:31PMBiogen Problems Strategy Make Avoid Seekingalpha
Oct-05-17$85.64 (-0.5%)
03:13PMWhy Glaukos Corp. Stock Sank 12.8% in September Fool
12:30PMTime Trust Gilead Seekingalpha
Oct-04-17$86.07 (-0.67%)
02:02PMBest Healthcare Stocks Abbvie Seekingalpha
Oct-03-17$86.65 (+0.36%)
09:40AMRetirement Strategy Dividend Growth Investing Like Fine Wine Seekingalpha
Oct-02-17$86.34 (+1.88%)
11:11AMRoche Shoring Biosimilar Wave Seekingalpha
08:00AM3 Things Biotech Learn Today October 2 2017 Seekingalpha
05:19AMStarting Point Big Pharma Novartis Sanofi Clear Hurdles Seekingalpha
Sep-30-17
08:00AM3 Things Biotech Learn Today September 30 2017 Seekingalpha
Sep-29-17
12:15PMBetter Healthcare Dividend Stock Pfizer Novartis Seekingalpha
11:08AMEli Lilly Strives Counteract Rivals Seekingalpha
08:00AM3 Things Biotech Learn Today September 29 2017 Seekingalpha
Sep-28-17$84.75 (+0.21%)
03:44PMGlaxosmithkline Get Ready Dividend Cut Pharma Giant Seekingalpha
11:33AMCelldex Therapeutics Buy Part 2 Seekingalpha
Sep-27-17$84.57 (-0.79%)
02:13PMRetirement Strategy Realty Income Personal Buy Zone Seekingalpha
08:00AM3 Things Biotech Learn Today September 27 2017 Seekingalpha
Sep-26-17$85.24 (-1.15%)
09:00AMRetirement Strategy Wrong Apple Seekingalpha
Sep-25-17$86.23 (+0.08%)
08:00AM3 Things Biotech Learn Today September 25 2017 Seekingalpha
Sep-23-17
09:00AMRetirement Strategy Bank America Tarp Ii Seekingalpha
Sep-21-17$84.94 (-0.98%)
01:40PMCrispr Field Patent Fight Extended Focus Science Time Frames Risks Seekingalpha
Sep-19-17$85.85 (+0.87%)
02:11PMPrefer Novartis Gilead Seekingalpha
Sep-18-17$85.11 (-0.55%)
01:50PMNovartis Nvs Investor Presentation Slideshow Seekingalpha
12:25PMTeva Pharmaceutical Opportunity Falling Knife Part 2 Seekingalpha
10:51AMRetirement Strategy Team Alpha Retirement Portfolio Ii Younger Investor Seekingalpha
10:10AMNovartis Value Creator Seekingalpha
Sep-14-17$85.83 (+0.34%)
02:09PMSwoop Pick Regeneron Month Seekingalpha
10:47AMCar T Therapy Fda Approved Slingshot Insights Idea Month Seekingalpha
Sep-13-17$85.54 (-0.21%)
04:40PMKite Gilead Winners Losers Part 2 Seekingalpha
09:18AMXoma License Model Catching Waves Seekingalpha
Sep-12-17$85.72 (+0.15%)
08:00AM3 Things Biotech Learn Today September 12 2017 Seekingalpha
Sep-11-17$85.59 (-0.05%)
04:57PMGilead Price Car T High Kymriah Seekingalpha
04:57PMWeekly Pharma Scoop Valeants Crl Resolution Eagle Undervalued Array Positive Results Seekingalpha
12:03PMBig Pharma Google Invest Rani Therapeutics Seekingalpha
08:54AMCooper Companies Still Comes Valuation Seekingalpha
Sep-08-17$85.63 (+0.39%)
08:20AMIntellia Long Haul Seekingalpha
Sep-01-17$83.81 (-0.57%)
03:07PMGilead's Plans To Acquire Kite Pharma Just Got Big-Time Validation From Novartis Seekingalpha
10:07AMNovartis: History Made For The Future Of Cancer Treatments Seekingalpha
08:00AM3 Things In Biotech You Should Learn Today: September 1, 2017 Seekingalpha
Aug-31-17$84.29 (+1.87%)
04:23PMGilead's Acquisition Of Kite Pharma Relieves Shareholders' Ennui Seekingalpha
01:31PMGilead's Competition: Other Stocks To Watch In Immunotherapy Seekingalpha
09:18AMGilead Sciences' Purchase Deal With Kite Pharma: Potential Scenarios And Associated Actions Seekingalpha
08:00AM3 Things In Biotech You Should Learn Today: August 31, 2017 Seekingalpha
Aug-30-17$82.74 (-1.05%)
10:51AMKite-Gilead: Winners And Losers Seekingalpha
Aug-29-17$83.62 (+0.35%)
03:22PMGilead And Kite: A Good Combination? Seekingalpha
11:30AMGilead Looks To Become The White Knight Of CAR-T Seekingalpha
08:00AM3 Things In Biotech You Should Learn Today: August 29, 2017 Seekingalpha
Aug-28-17$83.33 (-0.24%)
03:32PMThoughts On Gilead Trying To Fly With Kite Seekingalpha
02:02PMXoma Just Saved Itself Again Seekingalpha
01:11PMNovartis (NVS) Updates On ACZ885 (Canakinumab) - CANTOS study results - Slideshow Seekingalpha
09:00AM3 Things In Biotech You Should Learn Today: August 28, 2017 Seekingalpha
07:51AMNovartis AG: The Reliable European Healthcare Stock Seekingalpha
Aug-26-17
09:00AM3 Things In Biotech You Should Learn Today: August 26, 2017 Seekingalpha


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK